Aberrant p53 immunostaining patterns in breast carcinoma of no special type strongly correlate with presence and type of TP53 mutations.
Armbruster H, Schotte T, Götting I, Overkamp M, Granai M, Volmer LL, Bahlinger V, Matovina S, Koch A, Dannehl D, Engler T, Hartkopf AD, Brucker SY, Bonzheim I, Fend F, Staebler A, Montes-Mojarro I.
Armbruster H, et al. Among authors: overkamp m.
Virchows Arch. 2024 Oct;485(4):631-642. doi: 10.1007/s00428-024-03897-3. Epub 2024 Aug 27.
Virchows Arch. 2024.
PMID: 39191994
Free PMC article.